Advisory Services Network’s Apellis Pharmaceuticals APLS Stock Holding History

Advisory Services Network's APLS Position: Q2 2026 in Review

Advisory Services Network sold out of Apellis Pharmaceuticals (APLS) in Q2 2026, closing a stake of 105 shares — an estimated $4.22K sold.

Advisory Services Network first reported a position in APLS in Q3 2025 and held it in 2 quarters. The position peaked at $4.22K in Q1 2026. 1 fund tracked by Wall St. Rank holds APLS as of Q2 2026.

• Advisory Services Network reported no remaining Apellis Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
• Advisory Services Network sold 105 Apellis Pharmaceuticals shares in Q2 2026, an estimated $4.22K.
• Advisory Services Network first reported a position in Apellis Pharmaceuticals in Q3 2025 and held it in 2 quarters.
• Advisory Services Network's Apellis Pharmaceuticals position peaked at $4.22K in Q1 2026.
• 1 fund tracked by Wall St. Rank held Apellis Pharmaceuticals as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.